johnpaulca 12,036 posts msg #144589 - Ignore johnpaulca |
9/7/2018 10:47:53 AM
TSLA...down 7%....I kept saying this stock is way overpriced, it's not worth more than GM($35)....way overhyped, this why I kept shorting it.
|
four 5,087 posts msg #144590 - Ignore four modified |
9/7/2018 1:16:33 PM

|
four 5,087 posts msg #144591 - Ignore four modified |
9/7/2018 2:24:24 PM
Same chart as above, added std deviation values.

|
four 5,087 posts msg #144613 - Ignore four |
9/9/2018 6:04:30 PM

|
Eman93 4,750 posts msg #144653 - Ignore Eman93 |
9/13/2018 7:23:44 AM
EDC looks ready for a bounce.
|
johnpaulca 12,036 posts msg #144654 - Ignore johnpaulca |
9/13/2018 9:00:54 AM
I'm betting on BA to get over $354 for the breakout
|
johnpaulca 12,036 posts msg #144655 - Ignore johnpaulca |
9/13/2018 9:31:55 AM
johnpaulca
11,836 posts
msg #144654 9/13/2018 9:00:54 AM
I'm betting on BA to get over $354 for the breakout
**********************************************************
nice little pop...now above $360..will be cashing out soon.
|
Eman93 4,750 posts msg #144717 - Ignore Eman93 |
9/21/2018 6:29:43 AM
ERY and DUST over sold here. DUST looks like its building a Right shoulder.
|
four 5,087 posts msg #144718 - Ignore four |
9/21/2018 9:53:34 AM
Looking for volatility... ?
GTx Inc. stock drops 94% premarket after phase 2 trial failure
GTx Inc. stock dropped as much as 94% in Friday premarket trade after the company said that enobosarm, its therapy intended for post-menopausal women with stress urinary incontinence, did not meet the primary endpoint in a phase 2 clinical trial. The double-blind and placebo-controlled trial had enrolled nearly 500 women. Enobosarm is the company's
|
johnpaulca 12,036 posts msg #144720 - Ignore johnpaulca |
9/21/2018 11:36:36 AM
Eman93
4,703 posts
msg #144717
- Ignore Eman93 9/21/2018 6:29:43 AM
ERY and DUST over sold here. DUST looks like its building a Right shoulder.
**************************************************************************************
Dust....sell the oversold bounce will be my trade.
|